Invention Grant
- Patent Title: Cyanopyrimidinones
- Patent Title (中): 氰基嘧啶酮
-
Application No.: US10586501Application Date: 2004-12-31
-
Publication No.: US08088769B2Publication Date: 2012-01-03
- Inventor: Martin Hendrix , Lars Bärfacker , Heike Heckroth , Dagmar Karthaus , Adrian Tersteegen
- Applicant: Martin Hendrix , Lars Bärfacker , Heike Heckroth , Dagmar Karthaus , Adrian Tersteegen
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: DE102004001873 20040114
- International Application: PCT/EP2004/014872 WO 20041231
- International Announcement: WO2005/068436 WO 20050728
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04
Abstract:
The invention relates to novel cyanopyrimidinones, process for their preparation, and the use thereof for producing medicaments for improving perception, concentration, learning and/or memory.
Public/Granted literature
- US20080255118A1 Cyanopyrimidinones Public/Granted day:2008-10-16
Information query
IPC分类:
